Real-time metabolic profiling of oesophageal tumours reveals an altered metabolic phenotype to different oxygen tensions and to treatment with Pyrazinib.

Scientific Reports
Amy M BuckleyJacintha O'Sullivan

Abstract

Oesophageal cancer is the 6th most common cause of cancer related death worldwide. The current standard of care for oesophageal adenocarcinoma (OAC) focuses on neoadjuvant therapy with chemoradiation or chemotherapy, however the 5-year survival rates remain at < 20%. To improve treatment outcomes it is critical to further investigate OAC tumour biology, metabolic phenotype and their metabolic adaptation to different oxygen tensions. In this study, by using human ex-vivo explants we demonstrated using real-time metabolic profiling that OAC tumour biopsies have a significantly higher oxygen consumption rate (OCR), a measure of oxidative phosphorylation compared to extracellular acidification rate (ECAR), a measure of glycolysis (p = 0.0004). Previously, we identified a small molecule compound, pyrazinib which enhanced radiosensitivity in OAC. Pyrazinib significantly inhibited OCR in OAC treatment-naïve biopsies (p = 0.0139). Furthermore, OAC biopsies can significantly adapt their metabolic rate in real-time to their environment. Under hypoxic conditions pyrazinib produced a significant reduction in both OCR (p = 0.0313) and ECAR in OAC treatment-naïve biopsies. The inflammatory secretome profile from OAC treatment-naïve biopsies ...Continue Reading

References

Feb 24, 1956·Science·O WARBURG
Sep 1, 2005·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·M M M Abdel-LatifJ V Reynolds
Oct 1, 2010·The Journal of Thoracic and Cardiovascular Surgery·Jian ZhangDaniel Raftery
Jun 7, 2011·Oncogene·P DentelliM F Brizzi
Sep 14, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Miao-Fen ChenKuan-Der Lee
Oct 12, 2011·Annual Review of Cell and Developmental Biology·Sophia Y Lunt, Matthew G Vander Heiden
Aug 31, 2012·Oncoimmunology·Adriana J MichielsenElizabeth J Ryan
Dec 18, 2012·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Sine HadrupPer Thor Straten
May 11, 2013·International Journal of Cancer. Journal International Du Cancer·Roger A VaughanKristina A Trujillo
Jun 25, 2013·Molecular and Cellular Endocrinology·Xinguo Jiang, David J Shapiro
Jul 21, 2015·Nature Medicine·Andrew J GentlesAsh A Alizadeh
Jan 16, 2016·Cell Metabolism·Natalya N Pavlova, Craig B Thompson
Aug 30, 2016·The Journal of Clinical Investigation·Robert A JonesEldad Zacksenhaus
Apr 27, 2017·Scientific Reports·Valentina CappelloMauro Gemmi
Jun 27, 2017·The Journal of Clinical Investigation·Mark AyersTerrill K McClanahan
Jul 19, 2017·Trends in Cancer·Gabriela Jiménez-Valerio, Oriol Casanovas
Dec 14, 2017·Molecular Immunology·Sandra E NicholsonGabrielle T Belz
Feb 9, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Thomas M AshtonGeoff S Higgins
May 16, 2018·Frontiers in Immunology·Patrick VoosGerhard Thiel
Sep 1, 2018·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Ross D DolanDonald C McMillan
Sep 12, 2018·Proceedings of the National Academy of Sciences of the United States of America·Martin BenejNicholas C Denko
Jan 24, 2019·Cancers·Hui WangMark De Ridder

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
biopsy
ELISA
flow cytometry
xenografts
density gradient centrifugation
FCS
FACS

Software Mentioned

MSD Discovery Workbench
GraphPad
FlowJo
GraphPad Prism

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.